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We have sbown that inhibition of protein kinase C by I-S-isoquinolinytsulfonyl-2-methylpiperane. H7, induces differentiation and inhibits prolifer- 
ation of Nemo 2a ceils. We have now tested if H7 is able to inhibit proliferation of: I) human tumor cell lines from tissues other than brain; 
and 2) primary cultured cells from several human brain tumors. H7 inhibits, in a dosedependent manner, proliferation of all human tumor cell 
lines tcsted and of primary cultured cells from human brain tumors. These results indicate that inhibition of protein kinase C inhibits proliferation 
of tumoral cells, therefore, H7, and likely other inhibitors of protein kinase C, could be useful in the clinical treatment of brain (and probably 
other) tumors. 
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1. INTRODUCTION 
‘Tumors originate from cells with altered growth 
regulation which proliferate exponentially. Much recent 
research on the clinical treatment of tumors has been 
focused on the use of agents that induce differentiation 
and thereby inhibit proliferation [1,2]. 
We have recently found that inhibition of protein 
kinase C, the Ca*+/phospho~ipid-dependent protein 
kinase, induces differentiation and inhibits prolifera- 
tion of the clonal cell line Neuro-Za, C-1300 mouse 
neuroblastoma [3,4]. The aim of the present work was 
to assess if the inhibition of protein kinase C could also 
inhibit proliferation of: (i) human tumor cell lines from 
tissues other than brain; and (ii) human brain tumors in 
culture. 
2. MATERIALS AND METHODS 
2. I . Cell lines 
The human rhabdomyosarcoma A-204, osteogenic sarcoma HOS 
and breast adenocarcinoma MCF-7 cell lines were kindly provided by 
Dr Llombart (Dept. Pathology, University of Valencia, Spain). The 
cells were cultured in RPMI-1640 medium supplemented with 20% 
fetal bovine serum, 2 mM glutamine, 100 IU/ml of penicillin and 
lOO&mI of streptomycin (Flow Laboratories) at 37OC in 5% CO2 iu 
a humidified incubator. For cell viability determination, cells were 
seeded at 2O~~/mt, after 24 h, H7 was added and, 24 h later, cells 
were harvested by trypsinization. Viability was dctermincd by the 
Trypan blue exclusion mcrhod. For assays of DNA synthesis, cells 
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3 h (UNA synthesis) or 24 h (cell viability). Viability for non-treated 
cells ranged bctwccn 90 and 100%. 
were seeded at IOOOOO/mI in Nunc plates. H7 was added after ‘24 h 
and 3 h later S&i OS [3H]thymidine (5 Ci/mmol; 1 mCi/ml) were 
added. Cells were incubated for one hour and trichloroacetic acid 
precipitable radioactivity was counted. 
2.2. Human brain lumors 
Cells derived from the indicated human brain tumors were cultured 
in Ham’s FL0 medium containing 10% inactivated (S6”C, 30 min) 
fetal bovine serum and (per ml) 100 Ill penicilhn, IOOpg strep- 
tomycin and 9Opg gentamicin. Medium was changed at least twice 
weekly and no passage was carried out to avoid alterations, i.e. in 
chromosome number. After 8-20 days of cuhure H7 was added to 
some flasks. One hour later 4O&i/ml of [3H]thymidine 
(25 Ci/mmol) were added and, after 20 h of incubation, the radioac- 
tivity incorporated into trichloroacetic acid-precipitable material was 
counted. 
3. RESULTS AND DISCUSSION 
As shown in Table I, 117 inhibits the proliferation of 
all human tumor cell lines tested. The inhibition ranged 
between 33% for breast adenocarcinoma nd 75% for 
rhabdomyosarcoma. H7 did not affect cellular viability 
Table I 
Effect of H7 on DNA synthesis and cell viability of three human 
tumor cell lines 
Cell line DNA synthesis Cell viability 
(90 of control) (@+bo) 
Osteogenic sarcoma @IUS) 51 39 
Breast adenocarcinotna (MCF-7) 67 93 
Rhabdomyosarcoma (A-204) 25 89 
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Effect of H7 on the proliferation of human brain tumors 
Tumor 070 of inhibition of 
DNA synthesis/mg protein 
5OOpM H7 700pM H7 
Multiform glioblastoma 46 - 
Flypophyseal adenoma 77 94 
Meningioma I 87 88 
Meningioma 2 80 87 
Meningioma 3 67 87 
Metastatic carcinoma 76 89 
0.0 0.2 0.4 0.6 0.6 1.0 
HI (mM) 
Cells derived from the indicated human brain tumors were cultured as 
described in Materials and Methods. Incorporation of 13Hlthymidine 
into trichloroacetic acid-precipitable material was determined in the 
absence or the presence of the indicated concentrations of H7. 
Fig. 2. Dose-dependent inhibition by H7 of DNA synthesis in cells 
from a metastatic carcinoma. Cells were incubated in the absence or 
the presence of the indicated amounts of H7 and DNA synthesis was 
measured as described in Table I. Values are expressed as % of 
control. 
of breast adenocarcinoma or rhabdomyosarcoma but 
was significantly cytotoxic for osteogenic sarcoma. 
Primary cultured cells were prepared from the 
following tumors: multiform glioblastoma, hypophy- 
seal adenoma, meningioma and metastatic carcinoma. 
As shown in Fig. 1, I-(5-isoquinolinylsuIfonyl)-2- 
methylpiperazine (H7) induces the extension of neurite- 
like processes in primary cultured cells from 
hypophyseal adenoma and multiform glioblastoma. 
Similar results were obtained with the other tumors 
tested. 
As shown in Table II, H7 markedly inhibits the pro- 
liferation of all human brain tumors tested. At 500 PM 
H7, the inhibition ranged between 46% for the 
Fig. t , Effect of H7 011 the morphology of primary cultured hun~n brain tumor cells. Cells were incubakd with (l3,D) or wilhout (A,C) 5OOlr;Zl 
H7 ;Ind pholographcd aflcr IS h of trcamicnl. (A) and (f3) show ccllh from Ily~Wl~h~~scill ac crlo~na and (C) and (0) from multiform gliohlastnnl~. 
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Fig. 3. Effect of different concentrations of H7 on the morphology of cells from a mctastatic carcinoma. Cells wcrc incubated in the absence (A) 
or the presence of 0. I (B), 0.25 (C), 0.5 (D), 0.7 (E) or I .O (F) mivl H7. Cells were photographed IS II aficr ~hc additiotl of H7. 
glioblastoma and 87% for the meningioma. At 7OOpM 
H7 the proliferation of all tumors tested was inhibited 
by at least 87%. It should be noted that H7, at these 
doses, did not significantly affect cell viability. 
The percentage of inhibition was depcndcnt on rhc 
concentration of H7 added. This is shown in Fig. 2 for 
the mctastatic carcinoma. The effect was m&nun 
(89% inhibition) at 70014M H7. The morphological 
changes induced by incrcasiny concentrations of H7 arc 
shown in Fig. 3. Tkse results indicate that H7, and 
possibly other inhibitors of protcin kinasc C, could bc 
useful clinically. 
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